The present invention provides a composition for kidney treatment using the omentum, a medical kit for kidney treatment including the composition for kidney treatment using the omentum, and a film for kidney treatment including a cured product of the composition for kidney treatment using the omentum.

The present invention provides a composition for kidney treatment using the omentum, a medical kit for kidney treatment including the composition for kidney treatment using the omentum, and a film for kidney treatment including a cured product of the composition for kidney treatment using the omentum.

A triboelectrically neutral polymer material which resists charging when contacted with another material is provided. The polymer material comprises at least a first polymer and a second polymer, the first polymer having a first rating on a triboelectric series and the second polymer having a second rating on a triboelectric series that is more negative than the first rating. A method of preparing the polymer material is also provided.

A triboelectrically neutral polymer material which resists charging when contacted with another material is provided. The polymer material comprises at least a first polymer and a second polymer, the first polymer having a first rating on a triboelectric series and the second polymer having a second rating on a triboelectric series that is more negative than the first rating. A method of preparing the polymer material is also provided.

A triboelectrically neutral polymer material which resists charging when contacted with another material is provided. The polymer material comprises at least a first polymer and a second polymer, the first polymer having a first rating on a triboelectric series and the second polymer having a second rating on a triboelectric series that is more negative than the first rating. A method of preparing the polymer material is also provided.

An adhesive applicator (1) comprises a receiver (3) having a tubular body with a closed first end (13) and an opposed second end (15), the tubular body having a deformable wall (11), an adhesive composition contained within the tubular body, and an applicator tip (5) mounted on the tubular body and comprising a foam material (7) having an applicator (7a-7c) external of the applicator (1) for applying said adhesive, the applicator being such that deformation of the tubular body causes the adhesive to be expressed through the applicator tip (5), The foam material is a reticulated foam felt (7) and allows for relatively constant flow of the adhesive through the foam felt and to the applicator surface thereof over a wide range of viscosity conditions of the adhesive and pressure applied to the deformable body of the applicator (1).

An adhesive applicator (1) comprises a receiver (3) having a tubular body with a closed first end (13) and an opposed second end (15), the tubular body having a deformable wall (11), an adhesive composition contained within the tubular body, and an applicator tip (5) mounted on the tubular body and comprising a foam material (7) having an applicator (7a-7c) external of the applicator (1) for applying said adhesive, the applicator being such that deformation of the tubular body causes the adhesive to be expressed through the applicator tip (5), The foam material is a reticulated foam felt (7) and allows for relatively constant flow of the adhesive through the foam felt and to the applicator surface thereof over a wide range of viscosity conditions of the adhesive and pressure applied to the deformable body of the applicator (1).

Two-part cyanoacrylate compositions, methods for making same, and uses therefor are described. The compositions can be used to bond a variety of substrates including plastics and metals. The compositions remain effective after thermal ageing and humid ageing.

This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application.

This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application.